Single-institution experience using bevacizumab for IDH1/2 -mutant gliomas.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Collin Le, Chuyin Yang, Blaine S.C. Eldred, Terry J. Prins, Addison Fisher, Tie Li, Linda M. Liau, Richard G. Everson, Robert A. Chong, Phioanh Leia Nghiemphu, Timothy Francis Cloughesy, Catalina Raymond, Francesco Sanvito, Benjamin M. Ellingson, Albert Lai
Institution: University of California, Los Angeles
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410820561